CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Phosphoramidon, a novel matrix metalloproteinase inhibitor, inhibits significantly tumor growth independently of the application route (intraperitoneal [i.p.] versus intravenous [i.v.]) in a rat model of peritoneal carcinomatosis
DOI 10.1055/s-2005-920173
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Hribaschek, F Meyer, K Ridwelski, P Habermann, H Lippert
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe04/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Occurrence of peritoneal carcinomatosis remains still an unsolved problem in gastrointestinal cancer. Over the last years, novel antineoplastic substances such as matrix metalloproteinase (MMP) inhibitors have been investigated in animal models to achieve a decrease of tumor growth. The aim of the study was to determine whether i) Phosphoramidon, an MMP inhibitor, can prevent or diminish i.p. tumor gro…
Zitieren
Zitierempfehlung
A Hribaschek, F Meyer, K Ridwelski, P Habermann, H Lippert (2006) Phosphoramidon, a novel matrix metalloproteinase inhibitor, inhibits significantly tumor growth independently of the application route (intraperitoneal [i.p.] versus intravenous [i.v.]) in a rat model of peritoneal carcinomatosis. Zeitschrift für Gastroenterologie (04). https://doi.org/10.1055/s-2005-920173
Mit CareLit weiterarbeiten